These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4595328)

  • 1. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 2. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined drug and immunostimulation therapy against a syngeneic murine leukemia.
    Pearson JW; Chirigos MA; Chaparas SD; Sher NA
    J Natl Cancer Inst; 1974 Feb; 52(2):463-8. PubMed ID: 4593139
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of three strains of BCG against a murine leukemia after drug therapy.
    Sher NA; Pearson JW; Chaparas SD; Chirigos MA
    J Natl Cancer Inst; 1973 Dec; 51(6):2001-3. PubMed ID: 4587756
    [No Abstract]   [Full Text] [Related]  

  • 5. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

  • 6. L2C leukemia: a model of human acute leukemia.
    Murphy SG; LoBuglio AF
    Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
    [No Abstract]   [Full Text] [Related]  

  • 7. Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.
    Chirigos MA; Pearson JW; Pryor J
    Cancer Res; 1973 Nov; 33(11):2615-8. PubMed ID: 4795224
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia.
    Pearson JW; Chaparas SD; Chirigos MA
    Cancer Res; 1973 Aug; 33(8):1845-8. PubMed ID: 4720796
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.
    Lemonde P
    Natl Cancer Inst Monogr; 1973 Dec; 39():21-32. PubMed ID: 4362522
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG and cancer.
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of drug therapy against a histologically defined rat leukemia.
    Pearson JW; Chaparas SD; Torgersen JA; Perk K; Chirigos MA; Sher NA
    Cancer Res; 1974 Feb; 34(2):355-61. PubMed ID: 4589956
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy in previously treated acute lymphatic leukemia.
    Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
    Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
    [No Abstract]   [Full Text] [Related]  

  • 14. A cytokinetic analysis of bacillus calmette-guérin-induced growth control of a murine leukemia.
    Olsson L; Mathé G
    Cancer Res; 1977 Jun; 37(6):1743-9. PubMed ID: 322860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of M.bovis BCG and M.microti on sarcoma 180 growth in mice.
    Nedvĕdová V; Sír Z; Hyncica V; Buresová M
    Neoplasma; 1978; 25(6):685-90. PubMed ID: 377109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
    Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined chemoimmunostimulation therapy against murine leukemia.
    Pearson JW; Pearson GR; Gibson WT; Chermann JC; Chirigos MA
    Cancer Res; 1972 May; 32(5):904-7. PubMed ID: 4552917
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid.
    Drake WP; Cimino EF; Mardiney MR; Sutherland JC
    J Natl Cancer Inst; 1974 Mar; 52(3):941-4. PubMed ID: 4596992
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
    Bartlett GL; Purnell DM; Kreider JW
    Science; 1976 Jan; 191(4224):299-301. PubMed ID: 1108198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.